BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2223704)

  • 21. Abnormal blood rheology in retinal vein occlusion. A preliminary report.
    Peduzzi M; Debbia A; Guerrieri F; Bolzani R
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(1):83-5. PubMed ID: 3943743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of retinal venous occlusion with hemodilution and laser coagulation. Prevention of secondary glaucoma].
    Mach R; Susický P; Masopust J
    Cas Lek Cesk; 1997 Aug; 136(16):498-500. PubMed ID: 9441007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.
    Glacet-Bernard A; Chabanel A; Lelong F; Samama MM; Coscas G
    Ophthalmology; 1994 Sep; 101(9):1483-7. PubMed ID: 8090451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red cell deformability and other haemorheological variables in stable coronary artery disease.
    Low J; Dodds AJ; McGrath M; Biggs JC
    Thromb Res; 1985 May; 38(3):269-76. PubMed ID: 4024042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isovolemic hemodilution--one of the possibilities in therapy of retinal vein occlusion].
    Mach R
    Cesk Oftalmol; 1993 Oct; 49(5):308-12. PubMed ID: 8221946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors evaluation in some cardiovascular diseases.
    Puniyani RR; Ajmani R; Kale PA
    J Biomed Eng; 1991 Sep; 13(5):441-3. PubMed ID: 1795515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
    Cortinovis A; Crippa A; Crippa M
    Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.
    Wolf S; Arend O; Bertram B; Remky A; Schulte K; Wald KJ; Reim M
    Graefes Arch Clin Exp Ophthalmol; 1994 Jan; 232(1):33-9. PubMed ID: 8119599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood rheology in vitro and in vivo.
    Lowe GD
    Baillieres Clin Haematol; 1987 Sep; 1(3):597-636. PubMed ID: 3327559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hemorheological factors on the development of retinal vein occlusion.
    Michalska-Małecka K; Śpiewak D; Słowińska-Łożyńska L; Sierocka-Stępień J
    Clin Hemorheol Microcirc; 2016 May; 63(1):69-76. PubMed ID: 27163689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion.
    Chen HC; Wiek J; Gupta A; Luckie A; Kohner EM
    Br J Ophthalmol; 1998 Feb; 82(2):162-7. PubMed ID: 9613383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Panax notoginseng saponins combined isovolumic haemodilution on the retinal microcirculation of patients with retinal vein occlusion].
    Xi XH; Jiang DY; Tang CZ; Tan JQ; Nie AG
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):376-8. PubMed ID: 12206008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemorheologic changes in chronic polyarthritis].
    Schöps P; Seichert N; Thies W; Erdl R; Schattenkirchner M; Ernst E
    Z Rheumatol; 1988; 47(1):52-7. PubMed ID: 2453101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in blood filterability in cerebrovascular accidents.
    Boisseau MR; Freyburger G; Lorient-Roudaut MF
    Wien Med Wochenschr; 1986; 136 Spec No():44-6. PubMed ID: 3825170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
    Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
    Wiek J; Krause M; Wiederholt M; Hansen LL
    Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome.
    Brunner R; Widder RA; Fischer RA; Walter P; Bartz-Schmidt KU; Heimann K; Borberg H
    Transfus Sci; 1996 Dec; 17(4):493-8. PubMed ID: 10168545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemorheologic changes in ankylosing spondylitis].
    Ernst E; Roloff C; Magyarosy J; Drexel H
    Z Rheumatol; 1984; 43(4):190-2. PubMed ID: 6495894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of n-3 fatty acids on blood rheology.
    Ernst E
    J Intern Med Suppl; 1989; 731():129-32. PubMed ID: 2539829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemorrheological modifications during normal pregnancy].
    Huisman A
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):143-7. PubMed ID: 1767164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.